Medicine

HIV deterrence with PrEP in cisgender females

.STUDY HIGHLIGHT.06 August 2024.

A big randomized measured test along with cisgender females highlights the difficulties of obedience to a daily dental preexposure treatment program as well as demonstrates that twice-yearly shot of lenacapavir can maintain efficient HIV prevention degrees over 6 months.